Catheter-directed thrombolysis for the treatment of acute deep venous thrombosis

Applied Radiology

Volumn 30, Issue 7 SUPPL., 2001, Pages 29-35

  Antani, M R ^a  

^a ALBANY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; RETEPLASE; UROKINASE;

ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG COST; DRUG HALF LIFE; DRUG INFUSION; HUMAN; INTERVENTIONAL RADIOLOGY; LUNG EMBOLISM; MEDICAL SOCIETY; MORBIDITY; MORTALITY; PHLEGMON; POSTTHROMBOSIS SYNDROME; REVIEW; SURGICAL TECHNIQUE; SYMPTOM; THROMBECTOMY; TIME; VEIN CATHETERIZATION;

EID: 0034884726     PISSN: 01609963     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Pulmonary thromboembolism
2. Is embolic risk conditioned by location of deep venous thrombosis?
3. Venous thrombosis
4. Natural history of venous thromboembolism
5. Diagnosis of deep venous thrombosis
6. The relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: A one-to six-year follow-up
7. Hemodynamic deterioration in chronic venous disease
8. Advances in the treatment of phlegmasia cerulea dolens
9. Deep venous insufficiency: The relationship between lysis and subsequent reflux
10. Thrombolytic therapy for acute deep vein thrombosis
11. Massive vein thrombosis of the extremities
12. Transcatheter fibrinolytic therapy and angioplasty for left iliofemoral venous thrombosis
13. Iliofemoral deep venous thrombosis: Aggressive therapy using catheter-directed thrombolysis
14. Safety and efficacy of catheter-directed thrombolysis for iliofemoral venous thrombosis
15. Iliofemoral deep venous thrombosis: Safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy
16. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: Report of a national multi-center registry
17. Difficulties in obtaining sufficient amounts of urokinase
18. The safety, efficacy, and pharmacoeconomics of alteplase compared to urokinase for catheter-directed thrombolysis of arterial and venous occlusions
19. Alteplase as an alternative to urokinase
20. Initial results using reteplase for acute deep vein thrombosis
21. Combination therapy for acute myocardial infarction: Fibrinolytic therapy and glycoprotein llb/llla inhibition
22. Endovascular management of acute extensive iliofemoral deep venous thrombosis caused by May-Thurner syndrome
23. Transcatheter venous thrombolysis-Pitfalls and prat-falls: A case discussion of indications, technique, and alternatives
24. Prognostic value of CT prior thrombolytic therapy in iliofemoral DVT
25. Treatment of thrombosed dialysis access grafts: Randomized trial of surgical thrombectomy versus mechanical thrombectomy with the Amplatz device
26. Treatment of thrombosed hemodialysis access grafts: Arrow-Trerotola percutaneous thrombolytic device versus pulse-spray thrombolysis. Arrow-Trerotola Percutaneous Thrombolytic Device Clinical Trial
27. Standards for evaluating and reporting the results of surgical and percutaneous therapy for peripheral arterial disease
28. Shredding embolectomy thrombectomy catheter for treatment of acute lower-limb ischemia
29. Percutaneous recanalization of acutely thrombosed vessels by hydrodynamic thrombectomy (Hydrolyser)
30. Incorporating adjunctive mechanical thrombectomy into a catheter-directed pharmacological venous thrombolysis protocol: Preliminary results
31. Endovascular management of iliac vein compression (May-Thurner) syndrome
32. Reteplase in the treatment of peripheral arterial and venous occlusions: A pilot study
33. Mechanical thrombectomy in patients with deep venous thrombosis
34. Mechanical thrombolysis of venous thrombosis in an animal model using temporary caval filtration